hed by lobby groups. The result is an industry that is wasting billions of dollars of U.S. taxpayer money to support the boom in type II Diabetes. SCOTT BARLOW Scott Barlow is a contributor to ROB Insight, the business commentary service available to Globe Unlimited subscribers. ***** As a baby-boomer who